Non-Hodgkin lymphoma 

UCLH is considered a centre of excellence in the management of patients with Hodgkin’s and non-Hodgkin’s lymphoma. Our service treats patients with newly-diagnosed lymphoma as well as those with relapsed lymphoma from across the UK and abroad. We run several clinical trials – find out more about joining clinical trials here.

At UCLH you will have access to the latest treatments and technology and have a personal, individual care plan based around your needs. You will receive expert care from an experienced team in a safe and award winning environment. We offer a full range of treatments including chemotherapy, monoclonal antibody treatments, state-of-the-art radiotherapy, stem cell transplantation (both autologous and allogeneic (donor) transplantation). Our PET/CT scanners allow the most up-to-date imaging of patients.

We also provide emergency chemotherapy and intrathecal chemotherapy for patients who require it and run a lymphoma/HIV clinic for patients with lymphoma and a dual diagnosis of HIV. We also have a dedicated young adult cancer centre for young people diagnosed with lymphoma. Your treatment will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts. This is enhanced further by support from a dedicated team of Clinical Nurse Specialists (CNS) who complement the medical team and oversee your treatment journey. They offer on-going support from diagnosis and treatment to investigations and outcomes. This includes telephone advice and support when you are at home.


Dr Kirit Ardeshna, Divisional Clinical Director for Cancer and Consultant Haemato-oncologist

Dr Kirit Ardeshna is the lead blood diseases clinician at UCLH. He specialises in treating patients with haematological malignancies and has a particular interest in non-Hodgkin's and Hodgkin's lymphoma. He is also an honorary senior lecturer at UCL.

“The most rewarding part of my role at UCLH is curing some patients and helping others managing their long-term conditions so they can lead good quality lives.”

Full consultant profile

Dr Kate Cwynarski, Consultant Haematologist

Dr Cwynarski's interests are in lymphoma and chronic lymphocytic leukaemia with specialist interests in HIV-related lymphoma, primary CNS lymphoma, HTLV1-associated lymphoproliferative disease. She has been involved in writing lymphoma guidelines for BCSH and BHIVA.

Full consultant profile

Dr Charalampia Kyriakou, Consultant Haematologist

Dr Charalampia Kyriakou

Dr Kyriakou is a consultant haematologist. She is actively involved on national and international clinical trials in haematological diseases.

Dr Jonathan Lambert, Consultant Haemato-oncologist

Dr Jonathan Lambert

Dr Jonathan Lambert is a consultant haemato-oncologist at UCLH. He specialises in treating Myeloproliferative  neoplasms and  lymphoma.He is the clinical haematology undergraduate teaching programme at UCLH and lists his research interests as myeloproliferative neoplasms and lymphoma (particular interest in functional imaging in lymphoma).

“The most rewarding part of my work at UCLH is being  part of a dynamic, modern team with expertise in looking after people with even the most complex haematological cancers, and being able to provide cutting-edge anti-cancer therapies to patients who can benefit from them. I also greatly enjoy teaching students and other doctors”

Full consultant profile

Prof David Linch, Consultant Haematologist and Director of the UCL/UCLH Biomedical Research Centre Cancer Programme

Prof David Linch

Prof David Linch is a consultant haematologist and director of the University College London / UCLH Biomedical Research Centre Cancer Programme. He specialises in lymphoma, and focuses his research on the pathogenesis of acute myeloid leukaemia and the development of new therapeutic approaches in lymphoproliferative disorders.

Full consultant profile

Dr Christopher McNamara, Consultant Haematologist

Dr Christopher McNamara is a consultant haematologist with an interest in general haematology and haematological malignancies. His specialty interest is in lymphoma and he has published extensively on this subject.

Full consultant profile

Dr Sajir Mohamedbhai, Honorary Consultant Haematologist

Dr Sajir Mohamedbhai

Sajir Mohamedbhai is an honorary consultant haematologist. He is a member of the lymphoma team at UCLH and runs a general haematology clinic. He is involved in recruiting patients into clinical trials in lymphoma.

“I enjoy being part of a highly dedicated and friendly team, where everyone is committed to going the extra mile for our patients. It is particularly rewarding to see the positive impact this has on our patients' lives”

Full consultant profile

Dr Martin Pule

Dr Martin Pule

Dr Martin Pule as well as being a senior Lecturer at University College London, holds an honorary consultant post as a clinical haematologist at UCLH. He is the principle investigator in an open clinical study of engineered T-cells at UCLH.

Full consultant profile

Dr Andres Virchis, Consultant Haematologist

Dr Andres Virchis

Dr Andres Virchis holds a weekly lymphoma autograft clinic and attends the myeloma clinic on alternate weeks. He is also joint Haematology Tumour Board chair for the North London Cancer Network. Dr Virchis’s specialist interests are Hodgkin’s and non-Hodgkin’s lymphoma, and haematological stem cell transplantation.

Full consultant profile

 Clinical Nurse Specialists (CNS)

Fran Penny, Lymphoma Clinical Nurse Specialist

Fran is one of the lead clinical nurse specialists for haematology. She manages a team of nine clinical nurse specialists, covering lymphoma and myeloma.

She has worked as a clinical nurse specialist in a number of haematology specialties, and has a particular interest in lymphoma.

“The most enjoyable part of my role is working closely with patients and their families”

Micaela Plucinski, Lymphoma Association Clinical Nurse Specialist

Micaela Plucinski

Micaela supports young adults and adults with Hodgkin and Non Hodgkin Lymphoma. She has a special interest in supporting patients at the end of treatment.

"The most rewarding aspect of my job is being there to support patients at a vulnerable time in their lives. Being able to apply my expertise and specialised knowledge to make their journey easier is why I enjoy my role."